NGS diagnostic kit to detect major cancer-related mutations
Convenience of diagnosis
Enhanced diagnostic convenience using cfDNA in the blood
CRISPR/Cas9 system
Amplify mutant DNA after cutting wild-type DNA
High sensitivity
Enhanced detection limits using gcCas9
Reasonable cost
Compared to conventional NGS diagnostic kits, a larger number of samples can be analyzed in a single run
All-in-one platform
Integrated systems from diagnosis to analysis at once